These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. PtdIns(3,4,5)P(3) and inositol depletion as a cellular target of mood stabilizers. Teo R, King J, Dalton E, Ryves J, Williams RS, Harwood AJ. Biochem Soc Trans; 2009 Oct; 37(Pt 5):1110-4. PubMed ID: 19754462 [Abstract] [Full Text] [Related]
25. New understanding of mechanisms of action of bipolar medications. Sanacora G. J Clin Psychiatry; 2008 Oct; 69 Suppl 5():22-7. PubMed ID: 19265637 [Abstract] [Full Text] [Related]
26. Antidepressants increase glial cell line-derived neurotrophic factor production through monoamine-independent activation of protein tyrosine kinase and extracellular signal-regulated kinase in glial cells. Hisaoka K, Takebayashi M, Tsuchioka M, Maeda N, Nakata Y, Yamawaki S. J Pharmacol Exp Ther; 2007 Apr; 321(1):148-57. PubMed ID: 17210798 [Abstract] [Full Text] [Related]
29. Chronic antidepressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat. Sairanen M, O'Leary OF, Knuuttila JE, Castrén E. Neuroscience; 2007 Jan 05; 144(1):368-74. PubMed ID: 17049169 [Abstract] [Full Text] [Related]
30. Neurotrophic signaling cascades in the pathophysiology and treatment of bipolar disorder. Shaltiel G, Chen G, Manji HK. Curr Opin Pharmacol; 2007 Feb 05; 7(1):22-6. PubMed ID: 17055337 [Abstract] [Full Text] [Related]
33. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder. Ketter TA, Nasrallah HA, Fagiolini A. Psychopharmacol Bull; 2006 Feb 05; 39(1):120-46. PubMed ID: 17065977 [Abstract] [Full Text] [Related]